Literature DB >> 25521572

Interobserver agreement and accuracy of preoperative endoscopic ultrasound-guided biopsy for histological grading of pancreatic cancer.

Alberto Larghi1, Loredana Correale1, Riccardo Ricci2, Ihab Abdulkader3, Geneviève Monges4, Julio Iglesias-Garcia5, Marc Giovannini6, Fabia Attili1, Giovanna Vitale1, Cesare Hassan1, Guido Costamagna1, Guido Rindi2.   

Abstract

BACKGROUND AND STUDY AIM: Poorly differentiated/high grade pancreatic ductal adenocarcinoma (PDAC) is associated with an early unfavorable outcome, and patients with these tumors may be candidates for neo-adjuvant treatment. Endoscopic ultrasound-guided pancreatic fine-needle biopsy (EUS-FNB) may, in theory, allow preoperative assessment of PDAC histological grading. The aim of the current study was to assess the interobserver agreement and accuracy of preoperative PDAC grading from EUS-FNB specimens.
METHODS: Data from 42 postsurgical PDAC patients who had undergone preoperative EUS-FNB were retrieved. Four experienced pathologists independently reviewed the EUS-FNB slides and reported tumor grading (well, moderately, or poorly differentiated). Agreement among pathologists for grading of preoperative EUS-FNB samples was expressed by using Cohen's or Fleiss' kappa statistic, as appropriate. Postsurgical PDAC grading was used as the gold standard to assess the cumulative accuracy of EUS-FNB for the preoperative prediction of PDAC grading.
RESULTS: The kappa values for PDAC grading on EUS-FNB specimens ranged from 0.09 to 0.41. The total agreement among the four pathologists was only fair (κ = 0.27; 95 % confidence interval [CI] 0.14 - 0.38). When tumor grades were grouped as well or moderately differentiated vs. poorly differentiated, kappa values ranged from 0.19 to 0.50, with only a fair overall agreement (κ = 0.27; 95 %CI 0.21 - 0.49). The accuracy of preoperative grading from EUS-FNB was 56 % (75/134 readings; 95 %CI 40 % - 65 %), with mean sensitivity and specificity to detect a high grade, poorly differentiated tumor of 41 % (95 %CI 19 % - 54 %) and 78 % (53/68 readings; 95 %CI 60 % - 99 %), respectively.
CONCLUSIONS: Preoperative EUS-FNB-based histological grading of PDAC is unreliable, and current results do not support the use of this information in clinical practice. This appears to be due to suboptimal interobserver agreement among pathologists and an overall low accuracy in predicting postsurgical grading. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2014        PMID: 25521572     DOI: 10.1055/s-0034-1390912

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  8 in total

1.  Comparison of pancreatic histology specimens obtained by EUS 19G versus 22G core biopsy needles: A prospective multicentre study among experienced pathologists.

Authors:  Maria Chiara Petrone; Jan-Werner Poley; Matteo Bonzini; Ihab Abdulkader; Katharina Biermann; Genevieve Monges; Guido Rindi; Claudio Doglioni; Marco J Bruno; Marc Giovannini; Julio Iglesias-Garcia; Alberto Larghi; Paolo Giorgio Arcidiacono
Journal:  United European Gastroenterol J       Date:  2017-01-11       Impact factor: 4.623

2.  Interobserver agreement among cytopathologists in the evaluation of pancreatic endoscopic ultrasound-guided fine needle aspiration cytology specimens.

Authors:  Rawad Mounzer; Roy Yen; Carrie Marshall; Sharon Sams; Sanjana Mehrotra; Mohamed Sherif Said; Joshua C Obuch; Brian Brauer; Augustin Attwell; Norio Fukami; Raj Shah; Stuart Amateau; Matthew Hall; Lindsay Hosford; Robert Wilson; Amit Rastogi; Sachin Wani
Journal:  Endosc Int Open       Date:  2016-06-21

3.  Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling.

Authors:  Shi Wen; Bohan Zhan; Jianghua Feng; Weize Hu; Xianchao Lin; Jianxi Bai; Heguang Huang
Journal:  BMC Cancer       Date:  2017-11-02       Impact factor: 4.430

4.  Agreement on endoscopic ultrasonography-guided tissue specimens: Comparing a 20-G fine-needle biopsy to a 25-G fine-needle aspiration needle among academic and non-academic pathologists.

Authors:  Priscilla A van Riet; Djuna L Cahen; Katharina Biermann; Bettina Hansen; Alberto Larghi; Guido Rindi; Giovanni Fellegara; Paolo Arcidiacono; Claudio Doglioni; Nicola Liberta Decarli; Julio Iglesias-Garcia; Ihab Abdulkader; Hector Lazare Iglesias; Masayuki Kitano; Takaaki Chikugo; Satoru Yasukawa; Hans van der Valk; Nam Quoc Nguyen; Andrew Ruszkiewicz; Marc Giovannini; Flora Poizat; Schalk van der Merwe; Tania Roskams; Erwin Santo; Silvia Marmor; Kenneth Chang; Fritz Lin; James Farrell; Marie Robert; Juan Carlos Bucobo; Alan Heimann; Francisco Baldaque-Silva; Carlos Fernández Moro; Marco J Bruno
Journal:  Dig Endosc       Date:  2019-07-10       Impact factor: 7.559

5.  Plasma Extracellular Vesicle Characteristics Correlate with Tumor Differentiation and Predict Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgery with Curative Intent.

Authors:  David Badovinac; Katja Goričar; Hana Zavrtanik; Miha Petrič; Teja Lavrin; Nina Mavec; Vita Dolžan; Aleš Tomažič; Metka Lenassi
Journal:  J Pers Med       Date:  2021-01-28

6.  Development and multicenter validation of a CT-based radiomics signature for discriminating histological grades of pancreatic ductal adenocarcinoma.

Authors:  Na Chang; Lingling Cui; Yahong Luo; Zhihui Chang; Bing Yu; Zhaoyu Liu
Journal:  Quant Imaging Med Surg       Date:  2020-03

7.  The inflammatory milieu within the pancreatic cancer microenvironment correlates with clinicopathologic parameters, chemoresistance and survival.

Authors:  Daniel Delitto; Brian S Black; Heather L Sorenson; Andrea E Knowlton; Ryan M Thomas; George A Sarosi; Lyle L Moldawer; Kevin E Behrns; Chen Liu; Thomas J George; Jose G Trevino; Shannon M Wallet; Steven J Hughes
Journal:  BMC Cancer       Date:  2015-10-24       Impact factor: 4.430

8.  Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier.

Authors:  Manoj K Bhasin; Kenneth Ndebele; Octavian Bucur; Eric U Yee; Hasan H Otu; Jessica Plati; Andrea Bullock; Xuesong Gu; Eduardo Castan; Peng Zhang; Robert Najarian; Maria S Muraru; Rebecca Miksad; Roya Khosravi-Far; Towia A Libermann
Journal:  Oncotarget       Date:  2016-04-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.